Akumentis Healthcare Ltd
Favipiravir (800mg)
Codifab 800 Tablet is an antiviral medicine used for the treatment of mild to moderate coronavirus disease (COVID-19) in adults.
Tablet
Take Codifab 800 Tablet only as per the dose and duration suggested by your doctor. Do not self-medicate. The most common side effects of this medicine include the increased uric acid levels in blood, diarrhea, decreased white blood cell count (neutrophils), and increased liver enzymes. If any of these side effects bother you, consult with your doctor. To make sure it is safe for you, you should let your doctor know if you have severe kidney or liver disease before taking this medicine. Codifab 800 Tablet is not recommended for women who are pregnant, suspected to be pregnant or breastfeeding, as it can cause harmful effects to the developing baby. Also, inform your doctor if you have a history of hypersensitivity to this drug, have abnormalities in uric acid metabolism, or have gout.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Codifab 800 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Increased uric acid levels in blood Diarrhea Decreased white blood cell count (neutrophils) Increased liver enzymes
It is not known whether it is safe to consume alcohol with Codifab 800 Tablet. Please consult your doctor.
Codifab 800 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Codifab 800 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Codifab 800 Tablet is an antiviral medicine. It stops the SARS-CoV-2 virus from multiplying. By doing so, it decreases viral load in the body, restricts the spread of infection and helps in speeding up the recovery process.
Inform your doctor if you have gout, uric acid, liver, or kidney disease. Codifab 800 Tablet should be administered with care to elderly patients by monitoring their general conditions. Seek immediate medical attention if you see signs of allergic reactions like red or blistering rash, difficulty swallowing or breathing, swelling of the eyelids, lips, face, throat, or tongue. It is advisable to use contraceptive methods while taking Codifab 800 Tablet and for 7 days after the completion of the treatment. Let your doctor know if you are pregnant or breastfeeding.
Codifab 800 Tablet is an antiviral medicine that helps manage patients with mild to moderate COVID-19 infection.
Treatment with Codifab 800 Tablet should be initiated as soon as possible in mildly infected individuals, as early use of antiviral medicines is more effective in treating COVID-19 infection. Delaying treatment can slow down recovery and worsen symptoms like breathing issues, cough, or fever.
Patients with severe kidney or liver disease, those with abnormal uric acid levels or gout, children, pregnant women, breastfeeding mothers, and individuals allergic to the medicine's ingredients should not use Codifab 800 Tablet.
The recommended dose of Codifab 800 Tablet is 1,800 mg twice on day 1, followed by 800 mg twice daily up to day 14. The dosage and duration should be as advised by the doctor.
Codifab 800 Tablet should be given with care to the elderly, alongside regular monitoring. It has not been administered in children, as early experimental data suggests it may cause serious side effects in this age group.
No, Codifab 800 Tablet should not be used for treating COVID-19 infection in pregnant or breastfeeding women, as its use may cause harmful effects on the baby.
Codifab 800 Tablet inhibits the replication of the COVID-19 virus and stops its further spread within the human body, leading to faster recovery.
Codifab 800 Tablet should be stored at a temperature not more than 30 degrees Celsius and kept away from children's reach.
Yes, Codifab 800 Tablet may be given to patients with comorbidities such as diabetes and hypertension under medical supervision.